This Note discusses the regulatory framework for private antitrust litigation in China. It addresses some important issues in antitrust civil actions, including the jurisdictional options of anti-monopoly law (AML) cases, special burden of proof rules in AML violations, disclosure of leniency materials and the arbitrability of AML claims.